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Haemostatic activity of butanolic extracts of Lamium album 
and Lamium purpureum aerial parts
Lamium album and Lamium purpureum are species belonging 
to the genus Lamium. Aerial parts of the two species and 
roots of Lamium album have applications in human and 
veterinary traditional medicine. Haemostatic properties of 
butanolic extracts of Lamium species were investigated by 
two experimental models in Wistar rats: haemostatic test 
by tail bleeding time determination and acenocoumarol-
carrageenan test. Results of the haemostatic test by tail 
bleeding determination demonstrated haemostatic activity 
of both extracts. In the acenocoumarol-carrageenan test, 
only the Lamium album extract showed haemostatic activity, 
comparable to that of vitamin K. Based on the qualitative 
chemical data on iridoid glycosides (HPTLC), 
8-acetylshanzhiside methyl ester might be assumed to be 
responsible for haemostatic activity. Based on the acute 
toxicity test, none of the extracts showed toxicity. 
Keywords: Lamium album, Lamium purpureum, aerial parts, 
butanolic extract, haemostatic activity, toxicity
A large number of drugs that lead to improvement of human health and prolong life 
expectancy have been discovered lately. At the same time, new drugs have a considerable 
number of adverse effects. Today, more and more scientists are turning to medicinal plants, 
discovering natural chemical compounds with specific actions and mechanisms of 
performance.
Genus Lamium, which comprises about 40 species distributed in Europe, Asia and 
Africa, is less studied and much less utilized compared to other members of the Lamiaceae 
family to which it belongs (1). Lamium album and Lamium purpureum are species belonging 
to the genus Lamium. Aerial parts of the two species and roots of Lamium album have 
applications in human and veterinary traditional medicine; they possess diuretic, anti-
inflammatory, anti-diarrheal, astringent, expectorant, vasoconstrictor, antirheumatic, 
haemostatic and emollient properties (2). Lamium album is used in human medicine 
internally in leucorrhea, dysmenorrhea, prostate hypertrophy or inflammation, diarrhea, 
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externally in abscesses, tumors, varicose veins, ulcers, swellings caused by gout. Aerial 
parts of Lamium purpureum possess antirheumatic, astringent and emollient properties. 
Empirically, the plant is used to treat epilepsy, rheumatism, abscesses and wounds (2). 
As regards chemical composition, literature data indicate the presence of iridoid 
glycosides as main components (3), as well as benzoxazinoids, polyphenolic compounds, 
amino acids (4, 5), phenylethanoid and phenylpropanoid glycosides (1), phytoecdysteroids 
(6) and fatty and volatile oils (7) in both species of the genus Lamium. Lamium album and 
Lamium purpureum show notable differences in the qualitative and quantitative chemical 
composition of polyphenolic compounds (9).
In this paper, we present an investigation on the qualitative chemical composition of 
iridoid glycosides in butanolic extracts from Lamium album and Lamium purpureum aerial 
parts and their haemostatic properties, as well as their lack of toxicity.
EXPERIMENTAL
Plant material and extracts
Lamium album L. and Lamium purpureum L. aerial parts were obtained from the 
Fundulea Research Station (Romania) and dried and ground to fine powder. Voucher 
specimens are deposited in ICCF – Bucharest, Plant Material Storing Room.
Extracts were obtained by extraction with distilled water (pH 9.5 with CaCO3, vegetal 
material/solvent ratio 1:15, m/V) in a water bath at 50 °C for 2 hours, under continuous 
stirring. After filtration, the solution was centrifuged at 3000 rpm for 30 minutes. The 
resulting solution was concentrated to half its volume, under reduced pressure at 50 °C, 
with a rotary evaporator and extracted 5 times with butanol (water extract/butanol ratio, 
1:2, V/V). The butanolic solution obtained from liquid-liquid extraction was concentrated 
under reduced pressure at 50 °C to a thick extract. 
HPTLC analysis of iridoids
Qualitative analyses of iridoids were performed according to TLC Atlas – Plant Drug 
Analyses (10). Butanolic extracts were dissolved in HPLC grade methanol (50 %, V/V) to 
obtain a 1 % (m/V) solution. Reference substances, 8-acetyl shanzhiside methyl ester and 
shanzhiside methyl ester (PhytoLab, Germany) were also dissolved in methanol to prepare 
1 % (m/V) solutions. Then, 0.8–3 µL of the samples and 0.8–2.8 µL of reference substances were 
loaded as 10-mm bands onto 20 ´ 10 cm TLC plates (Silica gel 60F254, CAMAG LINOMAT 5 
instrument, Camag, Switzerland). The mobile phase was chloroform/methanol/water (60:40:4) 
(V/VV). After development, plates were dried and derivatised with sulphuric acid vanillin 
reagent at 100 °C. Fingerprints were evaluated in fluorescence mode at 254 nm (after deriva-
tisation) with the aid of WinCats and VideoScan software.
Experimental animals
Wistar rats and NRMI mice of both sexes were provided by the Institute Cantacuzino 
– Baneasa Branch (Romania) and used in in vivo experimental studies. All experiments 
complied with the regulations issued by FELASA (Federation of European Laboratory 
Animal Science Associations) and ARSAL (Romanian Association for Laboratory Animal 
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Science) and were approved by the ethics committees of the National Institute for Chemical- 
-Pharmaceutical R&D (ICCF-Bucharest, Romania) for animal experimentation.
Animals were housed under standard environmental conditions, at 22 ± 2 °C, relative 
humidity 50–60 %, under a 12-h dark-light cycle with free access to water and standard 
pellet diet. Rats were kept in the experimental facility for 7 days to get acclimated prior to 
dosing. Animals were deprived of food 12 hours prior to dosing.
Acute toxicity test
Male and female NRMI mice, weighing 18–20 g, were used. Extracts were administered 
orally by intragastric gavage as a 28 g per 100 mL aqueous suspension (prepared with 
Tween 80, 2 %) of the test sample in a dose of 7.00 mg kg–1 body mass, in a volume of 0.5 mL 
per 20 g bm (maximum for the species). After administration of the suspension, the 
animals were monitored each hour within the first 8 hours, and at least twice a day for 14 
days. On the last day of the experiment, the animals were euthanized observing the 
current rules for necropsy examination.
Haemostatic test by tail bleeding time determination
Male Wistar rats weighing 270–350 g were divided into three groups (n = 6). The 
control group (group 1) received distilled water, while groups 2 and 3 were administered 
Lamium purpureum extract and Lamium album extract, resp. The extract was administered 
orally, by intragastric gavage, as 1 % suspension (prepared with Tween 80, 2 % in distilled 
water), corresponding to a 50 mg kg–1 bm dose. Lamium purpureum extract and Lamium 
album extract suspensions and distilled water were administrated in a volume of 0.5 mL 
per 100 g bm, once a day for four consecutive days. On the fourth day, the haemostatic 
activity was evaluated by tail bleeding time determination after applying a scalpel incision 
onto animal tail. Before the incision, the animals were sedated with diazepam (Terapia 
SA., Romania) 2.5 mg kg–1 bm administered i.m. Tail skin was cleaned and disinfected, 
then an incision of 2 mm depth was made in the proximal region with a sterile scalpel once 
the timer started. The cut wound was dabbed with filter paper every 15 s until the bleeding 
stopped. Time from the incision until bleeding stopped was recorded as bleeding time (11).
Acenocoumarol carrageenan test
In this study, Wistar rats of both sexes, weighing 130–180 g, were used. Animals 
received a single subcutaneous dose of carrageenan (Sigma-Aldrich, USA) into the top of 
the skull, followed by acenocoumarol (Trombostop 2 mg tablets, Terapia Ranbaxy, 
Romania) administered orally for 3 days. For each animal with no haemostatic treatment, 
an extensive haematoma was observed at the carrageenan injection site on day four. 
Combined administration of an anticoagulant and carrageenan is a suitable means of 
inducing haemorrhagic necrosis in rats. Animals that received vitamin K before the 
subcutaneous injection of carageenan followed by acenocoumarol for 3 days had no 
haematoma at the carrageenan injection site.
Animals were divided into 10 groups (n = 12, 6 males and 6 females) for every test 
sample. On day one, the animals were treated as follows: the positive control group (group 
1) was treated with 1.35 mg kg–1 bm vitamin K per os (2 mL per 200 g bm); groups 2–5 were 
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treated with 1, 2, 4 and 10 % Lamium album extract, resp., (2 mL per 200 g bm); groups 6–9 
were treated with 1, 2, and 10 % Lamium purpureum extract, resp. (2 mL per 200 g bm); the 
negative control group (group 10) received distilled water (2 mL per 200 g bm).
On day two, the animals were sedated with diazepam 2.5 mg kg–1 bm administered i.m. 
Rats were epilated in the scalp region and then injected subcutaneously with carrageenan 
1 %, 0.05 mL per scalp region/animal. On the following 3 days, all animals received acenocou-
marol orally, 0.72 mg kg–1 as a daily dose (12). On the fifth day of the experiment, animals were 
euthanized according to the effective rules (13) and a transverse biretroauricular incision 
to the bone structures was made. The resulting flap was tractioned posteriorly in order to 
examine and reveal possible haematoma induced by carrageenan.
A presumptive haematoma prevention index was calculated.
Data analysis
The results were expressed as mean ± SD. The data were analysed using Student’s 
t-test.
RESULTS AND DISCUSSION
TLC profiles of the butanolic extracts of Lamium album and Lamium purpureum are 
shown in Fig. 1 and compared to reference substances, shanzhiside methyl ester and 
Fig. 1. TL chromatograms of butanol extracts of Lamium purpureum and Lamium album aerial parts.
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8-acetyl shanzhiside methyl ester (Figs. 2a,b). Shanzhiside methyl ester (Rf ~0.77) and 
8-acetyl shanzhiside methyl ester (Rf ~0.90) were preliminarily identified in Lamium album 
extract. In Lamium purpureum extracts only shanzhiside methyl ester was detected (Fig. 1).
Acute toxicity test
In the 14 days of the experiment, no signs of toxicity were recorded, nor any changes 
in spontaneous behaviour or in the appearance of animals. No deaths were recorded 
either. Macroscopic examination did not reveal any pathological modification of 
parenchymal organs, serous cavities or abnormal blood distribution. Thus, the tested 
extracts exerted no toxicity after a single 7.0 mg kg–1 oral dose. 
Fig. 2. Comparison between butanol extracts of Lamium purpureum and Lamium album aerial parts, and 
a) 8-acetyl shanzhiside methyl ester, and b) shanzhiside methyl ester (reference substance) fingerprints.
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Haemostatic test by tail bleeding time determination
Both tested extracts showed a decrease in bleeding time compared to the control 
(223.3 s): Lamium album extract with a medium bleeding time of 71.3 s (32 % of the control) 
and Lamium purpureum extract with 115 s (51 % of the control).
Acenocoumarol-carrageenan test
 In this experiment, performed to reveal the influence of the tested extracts upon a 
haematoma induced by subcutaneous injection of carrageenan into the top of the rat skull 
during oral treatment with acenocoumarol, the following was noticed.
Administration of 1.35 mg kg–1 bm vitamin K per os before administration of the phlo-
gistic agent (carrageenan) and followed by daily treatment with acenocoumarol for 3 days 
caused no haematoma at the carrageenan injection site. Preventive action of 10 % Lamium 
album extract was observed. Presumptive haematoma prevention index of 83 % for males 
and 67 % for females, compared to the preventive activity of vitamin K as 100 %, was cal-
culated.
The present study demonstrates the haemostatic activity of Lamium album extract only. 
Since 8-acetyl shanzshiside methyl ester was detected only in the Lamium album extract, it 
might be assumed as being responsible for this activity. This is in line with the research on 
Lamiophlomis rotata (Benth.) Kudo (LR), a plant species used in Chinese traditional medicine 
for haemostatic and pain relief effects (14). An extract of this species that contained iridoid 
glycosides showed satisfactory dose-dependent haemostatic activity, the major compounds 
of the extract being 8-dehydroxy shanzhiside, phloyoside II, shanzhiside methyl ester, 
loganin and 8-O-acetylshanzhiside methyl ester (by RP-HPLC) (14). Studies of this plant have 
also shown haemostatic properties of 8-O-acetylshanzhiside methyl ester in capillary 
coagulation tests and eye haemorrhage tests by significantly shortening the clotting time (15).
CONCLUSIONS
The obtained results confirm the traditional use of aerial parts of Lamium album for 
haemostatic activity, which makes it applicable in phytotherapeutic preparations of low/
no toxicity.
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